Royal Bank Of Canada Catalyst Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

  • $458 Billion
  • Q1 2025

A detailed history of Royal Bank Of Canada transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 213,469 shares of CPRX stock, worth $5.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
213,469
Previous 153,429 39.13%
Holding current value
$5.24 Million
Previous $3.2 Million 61.65%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$19.53 - $25.74 $1.17 Million - $1.55 Million
60,040 Added 39.13%
213,469 $5.18 Million
Q4 2024

Feb 14, 2025
SELL
$19.73 - $23.93 $110,152 - $133,601
-5,583 Reduced 3.51%
153,429 $3.2 Million
Q3 2024

Nov 14, 2024
BUY
$15.19 - $21.35 $1.3 Million - $1.83 Million
85,654 Added 116.76%
159,012 $3.16 Million
Q2 2024

Aug 14, 2024
BUY
$14.68 - $16.92 $109,777 - $126,527
7,478 Added 11.35%
73,358 $1.14 Million
Q1 2024

Nov 05, 2024
SELL
$13.18 - $17.11 $98,560 - $127,948
-7,478 Reduced 10.19%
65,880 $1.05 Million
Q1 2024

May 15, 2024
SELL
$13.18 - $17.11 $314,474 - $408,244
-23,860 Reduced 26.59%
65,880 $1.05 Million
Q4 2023

Feb 14, 2024
BUY
$11.78 - $17.29 $148,121 - $217,404
12,574 Added 16.29%
89,740 $1.51 Million
Q3 2023

Nov 14, 2023
SELL
$11.69 - $15.02 $139,905 - $179,759
-11,968 Reduced 13.43%
77,166 $902,000
Q2 2023

Aug 14, 2023
BUY
$11.5 - $18.08 $77,326 - $121,569
6,724 Added 8.16%
89,134 $1.2 Million
Q1 2023

May 15, 2023
SELL
$14.34 - $21.05 $85,036 - $124,826
-5,930 Reduced 6.71%
82,410 $1.37 Million
Q4 2022

Feb 14, 2023
BUY
$12.25 - $19.5 $488,334 - $777,348
39,864 Added 82.23%
88,340 $1.64 Million
Q3 2022

Nov 14, 2022
BUY
$7.06 - $15.52 $43,454 - $95,525
6,155 Added 14.54%
48,476 $622,000
Q2 2022

Aug 15, 2022
SELL
$6.23 - $8.57 $33,218 - $45,695
-5,332 Reduced 11.19%
42,321 $297,000
Q1 2022

May 16, 2022
SELL
$5.31 - $8.31 $67,893 - $106,251
-12,786 Reduced 21.16%
47,653 $394,000
Q4 2021

Feb 14, 2022
BUY
$5.21 - $7.45 $51,235 - $73,263
9,834 Added 19.43%
60,439 $410,000
Q3 2021

Nov 15, 2021
SELL
$4.85 - $6.04 $475,940 - $592,717
-98,132 Reduced 65.98%
50,605 $269,000
Q2 2021

Aug 16, 2021
BUY
$4.29 - $6.05 $638,081 - $899,858
148,737 New
148,737 $855,000

Others Institutions Holding CPRX

# of Institutions
388
Shares Held
99.3M
Call Options Held
37K
Put Options Held
20.5K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.52B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email